Fmr LLC Has $416,000 Position in R1 RCM Inc. (NASDAQ:RCM)

Fmr LLC raised its stake in R1 RCM Inc. (NASDAQ:RCM) by 113.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 29,369 shares of the healthcare provider’s stock after acquiring an additional 15,620 shares during the period. Fmr LLC’s holdings in R1 RCM were worth $416,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. GAMMA Investing LLC lifted its holdings in shares of R1 RCM by 41.3% during the 3rd quarter. GAMMA Investing LLC now owns 2,597 shares of the healthcare provider’s stock worth $37,000 after acquiring an additional 759 shares during the period. Allspring Global Investments Holdings LLC raised its position in R1 RCM by 589.2% during the third quarter. Allspring Global Investments Holdings LLC now owns 3,122 shares of the healthcare provider’s stock valued at $44,000 after purchasing an additional 2,669 shares in the last quarter. Values First Advisors Inc. bought a new stake in R1 RCM during the third quarter worth $88,000. ANTIPODES PARTNERS Ltd bought a new stake in R1 RCM during the second quarter worth $86,000. Finally, Creative Planning acquired a new stake in shares of R1 RCM in the 3rd quarter valued at $142,000. 61.10% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, Cantor Fitzgerald reissued a “neutral” rating and set a $14.30 price target on shares of R1 RCM in a report on Friday, October 4th. Twelve research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $15.73.

R1 RCM Stock Performance

Shares of RCM stock opened at $14.31 on Friday. The firm has a market capitalization of $6.04 billion, a price-to-earnings ratio of -95.39 and a beta of 0.84. The company has a current ratio of 1.79, a quick ratio of 1.79 and a debt-to-equity ratio of 0.76. The business’s 50-day moving average price is $14.28 and its 200-day moving average price is $13.71. R1 RCM Inc. has a 12 month low of $8.87 and a 12 month high of $15.12.

R1 RCM (NASDAQ:RCM) last issued its quarterly earnings data on Tuesday, November 5th. The healthcare provider reported ($0.05) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.04). R1 RCM had a negative net margin of 2.48% and a negative return on equity of 2.18%. The business had revenue of $656.80 million during the quarter, compared to the consensus estimate of $640.93 million. The company’s revenue was up 14.7% on a year-over-year basis. Equities research analysts forecast that R1 RCM Inc. will post -0.18 EPS for the current year.

About R1 RCM

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.